199 related articles for article (PubMed ID: 6234377)
21. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
22. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
23. Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.
Kiianmaa K; Attila LM
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):165-70. PubMed ID: 574195
[TBL] [Abstract][Full Text] [Related]
24. Effects of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine on the rat central nervous system after intraventricular or intracerebral application and on blood platelets in vitro.
Da Prada M; Pieri L; Keller HH; Pieri M; Bonetti EP
Ann N Y Acad Sci; 1978 Jun; 305():595-620. PubMed ID: 152083
[No Abstract] [Full Text] [Related]
25. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
Rodríguez FD; Rodríguez RE
Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
[TBL] [Abstract][Full Text] [Related]
26. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
27. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1985 Sep; 23(3):473-8. PubMed ID: 3931103
[TBL] [Abstract][Full Text] [Related]
28. The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.
Frankfurt M; Azmitia E
Brain Res; 1983 Feb; 261(1):91-9. PubMed ID: 6404500
[No Abstract] [Full Text] [Related]
29. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
Lima L; Sourkes TL
Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
[TBL] [Abstract][Full Text] [Related]
30. Effects of 5,7-dihydroxytryptamine and 6-hydroxydopamine on head-twitch response induced by serotonin, p-chloroamphetamine, and tryptamine in mice.
Orikasa S; Sloley BD
Psychopharmacology (Berl); 1988; 95(1):124-31. PubMed ID: 3133691
[TBL] [Abstract][Full Text] [Related]
31. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
[TBL] [Abstract][Full Text] [Related]
32. Interaction between noradrenergic and serotonergic mechanisms on the central regulation of blood pressure in the rat: a study using experimental central hypertension produced by chemical lesions of the locus coeruleus.
Ogawa M
Jpn Circ J; 1978 May; 42(5):581-97. PubMed ID: 151755
[TBL] [Abstract][Full Text] [Related]
33. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
[No Abstract] [Full Text] [Related]
34. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
35. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine on temperature regulation in rats.
Lin MT; Pang IH; Chern YF; Chern SI
J Pharm Pharmacol; 1978 Nov; 30(11):723-5. PubMed ID: 31440
[No Abstract] [Full Text] [Related]
36. Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: role of serotonin.
Benarroch EE; Balda MS; Finkielman S; Nahmod VE
Neuropharmacology; 1983 Jan; 22(1):29-34. PubMed ID: 6405300
[TBL] [Abstract][Full Text] [Related]
37. 6-Hydroxydopamine induces serotonergic axon sprouting in cerebral cortex of newborn rat.
Blue ME; Molliver ME
Brain Res; 1987 Apr; 429(2):255-69. PubMed ID: 3105821
[TBL] [Abstract][Full Text] [Related]
38. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
39. The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding.
Nazar M; Siemiatkowski M; Bidziński A; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
J Neural Transm (Vienna); 1999; 106(5-6):355-68. PubMed ID: 10443543
[TBL] [Abstract][Full Text] [Related]
40. [The response of monoamines in the rat brain to local vibration exposure].
Yamaguchi Y
Sangyo Igaku; 1985 Mar; 27(2):73-82. PubMed ID: 4068335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
